BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 1538123)

  • 1. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus.
    Wisnieski JJ; Jones SM
    J Immunol; 1992 Mar; 148(5):1396-403. PubMed ID: 1538123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG autoantibody to the collagen-like region of Clq in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus, and 6 other musculoskeletal or rheumatic diseases.
    Wisnieski JJ; Jones SM
    J Rheumatol; 1992 Jun; 19(6):884-8. PubMed ID: 1404125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Western blot analysis of human IgG reactive with the collagenous portion of C1q: evidence of distinct binding specificities.
    Mårtensson U; Sjöholm AG; Sturfelt G; Truedsson L; Laurell AB
    Scand J Immunol; 1992 Jun; 35(6):735-44. PubMed ID: 1604245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies in systemic lupus erythematosus and urticarial vasculitis.
    D'Cruz DP; Wisnieski JJ; Asherson RA; Khamashta MA; Hughes GR
    J Rheumatol; 1995 Sep; 22(9):1669-73. PubMed ID: 8523343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis.
    Cook AD; Rowley MJ; Wines BD; Mackay IR
    J Autoimmun; 1994 Jun; 7(3):369-78. PubMed ID: 7522456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome.
    Wisnieski JJ; Naff GB
    Arthritis Rheum; 1989 Sep; 32(9):1119-27. PubMed ID: 2528353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus.
    Marder RJ; Potempa LA; Jones JV; Toriumi D; Schmid FR; Gewurz H
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():25-34. PubMed ID: 6375256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocomplementemic urticarial vasculitis or systemic lupus erythematosus?
    Trendelenburg M; Courvoisier S; Späth PJ; Moll S; Mihatsch M; Itin P; Schifferli JA
    Am J Kidney Dis; 1999 Oct; 34(4):745-51. PubMed ID: 10516358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
    J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Anti-C1q Autoantibodies by Western Blot.
    Verlemyr A; Truedsson L; Skattum L
    Methods Mol Biol; 2019; 1901():183-189. PubMed ID: 30539577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus.
    Kohro-Kawata J; Wener MH; Mannik M
    J Rheumatol; 2002 Jan; 29(1):84-9. PubMed ID: 11824976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus.
    Sjoholm AG; Martensson U; Sturfelt G
    J Rheumatol; 1997 May; 24(5):871-8. PubMed ID: 9150075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypocomplementemic urticarial vasculitis: a rare presentation of systemic lupus erythematosus.
    Aydogan K; Karadogan SK; Adim SB; Tunali S
    Int J Dermatol; 2006 Sep; 45(9):1057-61. PubMed ID: 16961508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
    Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M
    Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic profile of normocomplementemic and hypocomplementemic urticarial vasculitis: a study from South India.
    Dincy CV; George R; Jacob M; Mathai E; Pulimood S; Eapen EP
    J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):789-94. PubMed ID: 18331318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
    Tsacheva I; Radanova M; Todorova N; Argirova T; Kishore U
    Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus.
    Frémeaux-Bacchi V; Weiss L; Demouchy C; Blouin J; Kazatchkine MD
    Lupus; 1996 Jun; 5(3):216-20. PubMed ID: 8803893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-C1q autoantibodies in lupus nephritis.
    Sinico RA; Rimoldi L; Radice A; Bianchi L; Gallelli B; Moroni G
    Ann N Y Acad Sci; 2009 Sep; 1173():47-51. PubMed ID: 19758131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-C1q autoantibodies.
    Kallenberg CG
    Autoimmun Rev; 2008 Sep; 7(8):612-5. PubMed ID: 18606253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.